Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 9, 2024
- Accession no.
- 0001447362-24-000192
- Filed
- Dec 9, 2024
- Trade date
- Dec 5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions. Open-market sales total $160.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Common Stock | SSaleDisposed | −1,972 | $31.35F2 | −$61,822.2 | 85,748 | Direct | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −1,010 | $31.35F2 | −$31,663.5 | 73,606 | Indirect | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −948 | $31.35F2 | −$29,719.8 | 62,943 | Indirect | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −300 | $31.35F2 | −$9,405 | 5,860 | Indirect | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −299 | $31.35F2 | −$9,373.65 | 5,852 | Indirect | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −299 | $31.35F2 | −$9,373.65 | 5,852 | Indirect | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −299 | $31.35F2 | −$9,373.65 | 5,852 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $31.070 to $31.675, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.